Sunshine Biopharma Inc. (SBFM) — Institutional Holders, Q2 2026
12 institutional investment managers reported a SBFM position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $33.2K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
SBFM 13F holders ranked 1–12 of 12
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | JANE STREET GROUP#1 · 14,974 sh | 14,974 | $31.4K | 0.00% | New |
| 2 | MORGAN STANLEY#2 · 385 sh | 385 | $808.00 | 0.00% | -97.4% |
| 3 | UBS Group AG#3 · 11,879 sh | 11,879 | $546.00 | 0.00% | -52.4% |
| 4 | SBI Securities , Ltd.#4 · 162 sh | 162 | $340.00 | — | -91.2% |
| 5 | Clear Street Group#5 · 449 sh | 449 | $27.00 | 0.00% | New |
| 6 | NATIONAL BANK OF CANADA#6 · 5 sh | 5 | $10.00 | 0.00% | -44.4% |
| 7 | OSAIC#7 · 2 sh | 2 | $4.00 | 0.00% | 0.0% |
| 8 | HRT FINANCIAL#8 · 52,616 sh | 52,616 | $2.00 | 0.00% | New |
| 9 | Caitong International Asset Management , Ltd#9 · 1 sh | 1 | $2.00 | 0.00% | New |
| 10 | Farther Finance Advisors#10 · 1 sh | 1 | $2.00 | — | 0.0% |
| 11 | TD Waterhouse Canada#11 · 1 sh | 1 | $2.00 | — | 0.0% |
| 12 | Strive Financial Group#12 · 1 sh | 1 | $2.00 | 0.00% | New |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.